Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Adenovirus and Oxaliplatin Cooperate as Agnostic Sensitizers For Immunogenic Cell Death in Colorectal Carcinoma.

Jessup JM, Kabbout M, Korokhov N, Joun A, Tollefson AE, Wold WSM, Mattoo AR.

Hum Vaccin Immunother. 2019 Oct 4. doi: 10.1080/21645515.2019.1665960. [Epub ahead of print]

PMID:
31584324
2.

Epigenetic re-wiring of breast cancer by pharmacological targeting of C-terminal binding protein.

Byun JS, Park S, Yi DI, Shin JH, Hernandez SG, Hewitt SM, Nicklaus MC, Peach ML, Guasch L, Tang B, Wakefield LM, Yan T, Caban A, Jones A, Kabbout M, Vohra N, NĂ¡poles AM, Singhal S, Yancey R, De Siervi A, Gardner K.

Cell Death Dis. 2019 Sep 18;10(10):689. doi: 10.1038/s41419-019-1892-7.

3.

MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.

Kabbout M, Dakhlallah D, Sharma S, Bronisz A, Srinivasan R, Piper M, Marsh CB, Ostrowski MC.

PLoS One. 2014 Jun 26;9(6):e100693. doi: 10.1371/journal.pone.0100693. eCollection 2014.

4.

Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.

Kadara H, Fujimoto J, Yoo SY, Maki Y, Gower AC, Kabbout M, Garcia MM, Chow CW, Chu Z, Mendoza G, Shen L, Kalhor N, Hong WK, Moran C, Wang J, Spira A, Coombes KR, Wistuba II.

J Natl Cancer Inst. 2014 Mar;106(3):dju004. doi: 10.1093/jnci/dju004. Epub 2014 Feb 22.

5.

ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer.

Kabbout M, Garcia MM, Fujimoto J, Liu DD, Woods D, Chow CW, Mendoza G, Momin AA, James BP, Solis L, Behrens C, Lee JJ, Wistuba II, Kadara H.

Clin Cancer Res. 2013 Jul 1;19(13):3383-95. doi: 10.1158/1078-0432.CCR-13-0341. Epub 2013 May 9.

6.

G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Fujimoto J, Kadara H, Garcia MM, Kabbout M, Behrens C, Liu DD, Lee JJ, Solis LM, Kim ES, Kalhor N, Moran C, Sharafkhaneh A, Lotan R, Wistuba II.

J Thorac Oncol. 2012 Dec;7(12):1747-1754. doi: 10.1097/JTO.0b013e31826bb1ff.

7.

Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.

Kadara H, Shen L, Fujimoto J, Saintigny P, Chow CW, Lang W, Chu Z, Garcia M, Kabbout M, Fan YH, Behrens C, Liu DA, Mao L, Lee JJ, Gold KA, Wang J, Coombes KR, Kim ES, Hong WK, Wistuba II.

Cancer Prev Res (Phila). 2013 Jan;6(1):8-17. doi: 10.1158/1940-6207.CAPR-12-0290. Epub 2012 Oct 19.

8.

Pulmonary adenocarcinoma: a renewed entity in 2011.

Kadara H, Kabbout M, Wistuba II.

Respirology. 2012 Jan;17(1):50-65. doi: 10.1111/j.1440-1843.2011.02095.x. Review.

9.

Transcription factor ets-2 plays an important role in the pathogenesis of pulmonary fibrosis.

Baran CP, Fischer SN, Nuovo GJ, Kabbout MN, Hitchcock CL, Bringardner BD, McMaken S, Newland CA, Cantemir-Stone CZ, Phillips GS, Ostrowski MC, Marsh CB.

Am J Respir Cell Mol Biol. 2011 Nov;45(5):999-1006. doi: 10.1165/rcmb.2010-0490OC. Epub 2011 May 11.

10.

Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.

Kabbout M, Hatoum A, Abou-Lteif G, Chakroun I, Homaidan FR, Darwiche N.

Mol Carcinog. 2004 May;40(1):12-23.

PMID:
15108326

Supplemental Content

Loading ...
Support Center